<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Transgene Biotek Ltd has filed a confirmation with BSE stating that it does not meet the criteria specified under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. The company confirms it does not fall under the category of a 'Large Corporate' as defined by SEBI guidelines for entities raising funds through debt securities. The filing is signed by Dr K Koteswara Rao, Chairman & Managing Director. This is a routine compliance confirmation filed by the company to declare its status regarding Large Corporate classification.
This filing has no direct impact on shareholders as it simply confirms the company's status. It indicates Transgene Biotek is a smaller entity that does not meet the thresholds for Large Corporate classification under SEBI regulations.